Abbott acquires Walk Vascular and its system to remove peripheral blood clots

Abbott (NYSE:ABT) announced today that it acquired Walk Vascular and its minimally invasive mechanical aspiration thrombectomy system.

Financial terms of the acquisition were not disclosed.

Walk Vascular designed its JETi peripheral thrombectomy system and the next-generation JETi AIO (all-in-one) peripheral thrombectomy system to remove intravascular peripheral blood clots that can reduce blood flow and lead to serious complications for patients.

Get the full story at our sister site, Medical Tubing & Extrusion.

Read more
  • 0